Dezerv

Fund Overview

Fund Size

Fund Size

₹2,613 Cr

Expense Ratio

Expense Ratio

0.95%

ISIN

ISIN

INF200K01UP2

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

No Charges

Inception Date

Inception Date

01 Jan 2013

About this fund

SBI Healthcare Opportunities Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by SBI Mutual Fund. This fund has been in existence for 11 years, 5 months and 17 days, having been launched on 01-Jan-13.
As of 14-Jun-24, it has a Net Asset Value (NAV) of ₹407.31, Assets Under Management (AUM) of 2612.73 Crores, and an expense ratio of 0.95%.
  • SBI Healthcare Opportunities Fund Direct Growth has given a CAGR return of 18.18% since inception.
  • The fund's asset allocation comprises around 96.56% in equities, 0.00% in debts, and 3.44% in cash & cash equivalents.
  • You can start investing in SBI Healthcare Opportunities Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+48.25%

+50.16% (Cat Avg.)

3 Years

+17.40%

+13.87% (Cat Avg.)

5 Years

+28.36%

+25.69% (Cat Avg.)

10 Years

+16.98%

+16.59% (Cat Avg.)

Since Inception

+18.18%

(Cat Avg.)

Portfolio Summaryas of 31st May 2024

Equity2,522.85 Cr96.56%
Others89.88 Cr3.44%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity350.35 Cr13.41%
Max Healthcare Institute Ltd Ordinary SharesEquity180.43 Cr6.91%
Cipla LtdEquity179.45 Cr6.87%
Divi's Laboratories LtdEquity172.29 Cr6.59%
Lonza Group Ltd ADREquity135.44 Cr5.18%
Aether Industries LtdEquity112.56 Cr4.31%
Mankind Pharma LtdEquity106.99 Cr4.09%
Aurobindo Pharma LtdEquity106.71 Cr4.08%
Jupiter Life Line Hospitals LtdEquity101.99 Cr3.90%
Lupin LtdEquity101.28 Cr3.88%
Gland Pharma LtdEquity99.37 Cr3.80%
Abbott India LtdEquity93.2 Cr3.57%
Krishna Institute of Medical Sciences LtdEquity91.31 Cr3.49%
Rainbow Childrens Medicare LtdEquity85.85 Cr3.29%
Fortis Healthcare LtdEquity85.52 Cr3.27%
Torrent Pharmaceuticals LtdEquity80.88 Cr3.10%
TrepsCash - Repurchase Agreement79.48 Cr3.04%
Global Health LtdEquity78.66 Cr3.01%
J.B. Chemicals & Pharmaceuticals LtdEquity66.45 Cr2.54%
Aster DM Healthcare Ltd Ordinary SharesEquity65.51 Cr2.51%
Zydus Lifesciences LtdEquity56.01 Cr2.14%
Alkem Laboratories LtdEquity48.1 Cr1.84%
Dr. Lal PathLabs LtdEquity39.72 Cr1.52%
Laurus Labs LtdEquity37.71 Cr1.44%
Gufic Biosciences LtdEquity30.8 Cr1.18%
Vijaya Diagnostic Centre LtdEquity16.27 Cr0.62%
Net Receivable / PayableCash - Collateral10.4 Cr0.40%

Allocation By Market Cap (Equity)

Large Cap Stocks

39.25%

Mid Cap Stocks

29.50%

Small Cap Stocks

27.82%

Allocation By Credit Quality (Debt)

A

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare2,410.29 Cr92.25%
Basic Materials112.56 Cr4.31%

Risk & Performance Ratios

Standard Deviation

This fund

14.03%

Cat. avg.

14.65%

Lower the better

Sharpe Ratio

This fund

0.76

Cat. avg.

0.55

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

0.92

Higher the better

Fund Managers

TD

Tanmaya Desai

Since June 2011

MJ

Mohit Jain

Since November 2017

Additional Scheme Detailsas of 31st May 2024

ISININF200K01UP2Expense Ratio0.95%Exit LoadNo ChargesFund Size₹2,613 CrAge01 Jan 2013Lumpsum Minimum₹5,000Fund StatusOpen Ended Investment CompanyBenchmarkBSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹13.07 Cr52.7%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹683.18 Cr55.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹683.18 Cr53.3%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹41.38 Cr50.7%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹156.65 Cr45.7%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹156.65 Cr42.9%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2201.96 Cr52.2%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2201.96 Cr50.0%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹552.77 Cr54.1%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹16.16 Cr49.5%

About the AMC

Total AUM

₹9,61,293 Cr

Address

C-38 & 39, G Block, Bandra Kurla Complex, Mumbai, 400 051

Other Funds by SBI Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
SBI Nifty50 Equal Weight Index Fund Direct Growth

Very High Risk

0.5%0.0%₹954.55 Cr-
SBI Fixed Maturity Plan (FMP) - Series 91 (90 Days) Direct Growth

Moderately High risk

-0.0%--
SBI Debt Fund Series C 24 Direct Growth

Low to Moderate Risk

-0.0%-4.4%
SBI Fixed Maturity Plan (FMP) - Series 47 (1434 Days) Direct Growth

Moderate Risk

-0.0%₹134.63 Cr7.2%
SBI Fixed Maturity Plan Series 41 1498 Days Direct Growth

Moderate Risk

-0.0%₹860.71 Cr7.2%
SBI Long Term Advantage Fund Series II Direct Growth

Very High Risk

-0.0%₹39.12 Cr43.7%
SBI Debt Fund Series C 25 Direct Growth

Low to Moderate Risk

-0.0%-5.1%
SBI Fixed Maturity Plan (FMP) - Series 60 (1878 Days) Direct Growth

Low to Moderate Risk

-0.0%₹229.08 Cr7.2%
SBI Fixed Maturity Plan (FMP) - Series 74 1243 Days Direct Growth

Low to Moderate Risk

---7.3%
SBI Fixed Maturity Plan Series 78 1170 Days Direct Growth

Low to Moderate Risk

-0.0%-7.1%
SBI Fixed Maturity Plan Series 66 1361 Days Direct Growth

Moderate Risk

-0.0%-7.2%
SBI Fixed Maturity Plan Series 57 1835 Days Direct Growth

Low to Moderate Risk

--₹238.17 Cr7.2%
SBI Fixed Maturity Plan (FMP) - Series 80 366 Days Direct Growth

Moderate Risk

-0.0%-7.6%
SBI Fixed Maturity Plan Series 1 3668 Days Direct Growth

Moderate Risk

-0.0%₹44.35 Cr7.3%
SBI Fixed Maturity Plan Series 81 1157 Days Direct Growth

Low to Moderate Risk

-0.0%-7.2%
SBI Fixed Maturity Plan (FMP) - Series 49 (1823 Days) Direct Growth

Low to Moderate Risk

-0.0%₹363.98 Cr7.3%
SBI Fixed Maturity Plan (FMP) - Series 75 (366 Days) Direct Growth

Moderate Risk

---7.5%
SBI Fixed Maturity Plan Series 46 1850 Days Direct Growth

Low to Moderate Risk

-0.0%₹122.49 Cr7.1%
SBI Fixed Maturity Plan Series 53 1839 Days Direct Growth

Low to Moderate Risk

--₹286.68 Cr7.3%
SBI Long Term Advantage Fund Series I Direct Growth

Very High Risk

-0.0%₹48.59 Cr44.0%
SBI Fixed Maturity Plan Series 79 1130 Days Direct Growth

Low to Moderate Risk

-0.0%-6.9%
SBI Long Term Advantage Fund Series VI Direct Growth

Very High Risk

-0.0%₹284.55 Cr49.5%
SBI Fixed Maturity Plan Series 76 1221 Days Direct Growth

Low to Moderate Risk

---7.0%
SBI Tax Advantage Fund Series III Direct Growth

Very High Risk

-0.0%₹33.26 Cr32.0%
SBI Fixed Maturity Plan Series 73 1226 Days Direct Growth

Low to Moderate Risk

---7.1%
SBI Fixed Maturity Plan Series 44 1855 Days Direct Growth

Low to Moderate Risk

-0.0%₹357.83 Cr7.2%
SBI Fixed Maturity Plan Series 65 367 Days Direct Growth

Low to Moderate Risk

-0.0%--
SBI Fixed Maturity Plan (FMP) - Series 58 (1842 Days) Direct Growth

Low to Moderate Risk

--₹232.72 Cr7.2%
SBI Fixed Maturity Plan (FMP) - Series 50 (1843 Days) Direct Growth

Low to Moderate Risk

--₹113.05 Cr7.0%
SBI Fixed Maturity Plan Series 52 1848 Days Direct Growth

Low to Moderate Risk

--₹127.27 Cr7.3%
SBI Fixed Maturity Plan Series 67 1467 Days Direct Growth

Low to Moderate Risk

-0.0%-7.2%
SBI Fixed Maturity Plan (FMP) - Series 54 (1842 Days) Direct Growth

Low to Moderate Risk

--₹34.91 Cr7.2%
SBI Fixed Maturity Plan Series 6 3668 Days Direct Growth

Moderate Risk

-0.0%₹32.09 Cr7.2%
SBI Fixed Maturity Plan Series 34 3682 Days Direct Growth

Moderate Risk

--₹25.47 Cr7.2%
SBI Fixed Maturity Plan Series 64 1169 Days Direct Growth

Low to Moderate Risk

-0.0%-7.0%
SBI Fixed Maturity Plan (FMP) - Series 59 (1618 Days) Direct Growth

Low to Moderate Risk

-0.0%₹26.01 Cr6.9%
SBI Long Term Advantage Fund Series III Direct Growth

Very High Risk

-0.0%₹71.58 Cr46.4%
SBI Long Term Advantage Fund Series V Direct Growth

Very High Risk

-0.0%₹315.32 Cr36.8%
SBI Fixed Maturity Plan Series 43 1616 Days Direct Growth

Low to Moderate Risk

-0.0%₹111.11 Cr7.2%
SBI Fixed Maturity Plan Series 45 1840 Days Direct Growth

Moderate Risk

-0.0%₹210.04 Cr7.3%
SBI Fixed Maturity Plan Series 69 367 Days Direct Growth

Moderate Risk

-0.0%-7.6%
SBI Long Term Advantage Fund Series IV Direct Growth

Very High Risk

-0.0%₹208.83 Cr35.1%
SBI Fixed Maturity Plan Series 56 1232 Days Direct Growth

Low to Moderate Risk

--₹269.91 Cr7.2%
SBI Fixed Maturity Plan (FMP) - Series 48 (1458 Days) Direct Growth

Low to Moderate Risk

-0.0%₹43.52 Cr7.1%
SBI Fixed Maturity Plan Series 68 1302 Days Direct Growth

Low to Moderate Risk

-0.0%-6.9%
SBI Fixed Maturity Plan Series 42 1857 Days Direct Growth

Low to Moderate Risk

-0.0%₹444.89 Cr7.2%
SBI Fixed Maturity Plan Series 63 372 Days Direct Growth

Low to Moderate Risk

-0.0%-6.3%
SBI Fixed Maturity Plan (FMP) - Series 51 (1846 Days) Direct Growth

Low to Moderate Risk

--₹277.25 Cr7.3%
SBI Fixed Maturity Plan (FMP) - Series 71 (364 Days) Direct Growth

Moderate Risk

---7.5%
SBI Fixed Maturity Plan Series (FMP) - 77 (366 Days) Direct Growth

Moderate Risk

-0.0%-7.7%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of SBI Healthcare Opportunities Fund Direct Growth, as of 14-Jun-2024, is ₹407.31.
The fund has generated 48.25% over the last 1 year and 17.40% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 96.56% in equities, 0.00% in bonds, and 3.44% in cash and cash equivalents.
The fund managers responsible for SBI Healthcare Opportunities Fund Direct Growth are:-
  1. Tanmaya Desai
  2. Mohit Jain